Avasimibe Pfizer
- PMID: 12498009
Avasimibe Pfizer
Abstract
Avasimibe (also known as CI-1011 or PD-148515) is a selective acyl-coenzyme A:cholesterol O-acyltransferase (ACAT) inhibitory lipid-regulating agent under development by Pfizer (formerly Parke-Davis) for the potential treatment of hyperlipidemia and atherosclerosis. The compound is currently undergoing phase III clinical trials [371470].
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources